Xu Qin-Qin, Sun Hui-Yan, Xiao Feng-Jun, Shi Xue-Feng, Li Yu-Xiang, Wang Hua, Wang Li-Sheng, Ge Ri-Li
Institute of High Altitude Medicine, Medical College of Qinghai University, Xining 810001, Qinghai Province, China; Qianghai People's Hospital, Xining 810007, Qinghai Province, China.
Department of Experimental Hematology, Institute of Radiation Medicine, Academy of Military Medical Sciences, Beijing 100850, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Aug;25(4):965-969. doi: 10.7534/j.issn.1009-2137.2017.04.001.
To clarify the roles of SPK pathway in the regulation of proliferation, survival and glucose consume of human erythroleukemia TF-1 cells.
The interfering in SPK expression of TF-1 cells was performed using leutivirus vector-mediated shRNA, the interference efficacy of SPK in TF-1 cells was detected by RT-qPCR and Western blot, the viability of TF-1 cell proliferation was detected by using CCK-8 method, the apoptosis of TF-1 cells was determined by flow cytmetry with Annexin V staining.
Hypoxia up-regulated the expression of HIF-1α, HIF-2α, and SPK in TF-1 cells. SPK treatment resulted in reduced proliferation and induced apoptosis in TF-1 cells. Furthermore, knockdown of the SPK significantly reduced utilization and consumption of glucose.
The SPK is key signalling molecule involved in regulation of hypoxia-induced proliferation and glucose metabolism in TF-1 cells, and plays an important rote in proliferation and energy metabolism of leukemia cells.
